Showing results (111-120 of 223) with videos related to

Sort By:
Pageof 23
Therapeutics and Clinical Risk Management|October 31, 2017
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectivesMarco Fiore, Alberto Enrico Maraolo, Sebastiano Leone, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 5, 2011
Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008Annapaola Callegaro, Valentina Svicher, Claudia Alteri, et al.
Patient Preference and Adherence|June 3, 2010
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjectsMonica Airoldi, Mauro Zaccarelli, Luca Bisi, et al.
Antiviral Therapy|November 3, 2010
Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation scoreJonathan M Schapiro, Joseph Scherer, Charles A Boucher, et al.
Saudi Journal of Anaesthesia|June 30, 2021
A scoping review of retracted publications in anesthesiologyMarco Fiore, Aniello Alfieri, Maria Caterina Pace, et al.
World Journal of Gastroenterology|July 26, 2017
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic reviewMarco Fiore, Alberto Enrico Maraolo, Ivan Gentile, et al.
European Journal of Gastroenterology & Hepatology|January 6, 2018
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysisMarco Fiore, Ivan Gentile, Alberto E Maraolo, et al.
World Journal of Hepatology|November 8, 2017
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitisMarco Fiore, Alberto Enrico Maraolo, Ivan Gentile, et al.
Medicine|September 8, 2016
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation CohortNicola Squillace, Laura Galli, Alessandra Bandera, et al.
The Lancet. Infectious Diseases|October 25, 2011
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trialJan van Lunzen, Franco Maggiolo, José R Arribas, et al.
Pageof 23